Neoplasm
RecruitingLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
France- Participants:18–64 years · 65+ years
- Substances:Adagrasib
- Sponsor:Bristol-Myers Squibb Services Unlimited Company
Rare diseases
Investigational molecules
Locations
Back to France57 clinical trials in Saint-Mande, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on non-small cell lung cancer (NSCLC) evaluating novel immunotherapy combinations and treatment approaches for both early-stage and metastatic disease.
Studies incorporate cutting-edge targeted therapies and innovative treatment strategies for different patient populations.
Research initiatives examining treatments for castration-resistant prostate cancer, including novel drug combinations and therapeutic approaches for both localized and metastatic disease.
Investigations focus on improving survival outcomes and treatment efficacy for various stages of prostate cancer.
Clinical trials exploring treatments for colorectal cancer and advanced gastric cancer, investigating innovative therapeutic combinations and targeted approaches.
Studies aim to advance personalized treatment strategies and improve patient outcomes.
Research focusing on chronic skin conditions including hidradenitis suppurativa and atopic dermatitis, testing new biological therapies.
Trials aim to develop more effective treatments for challenging dermatological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.